Li Yi-Xin, Zhou Liang, Lv Mo-Qi, Ge Pan, Liu Yi-Chen, Zhou Dang-Xia
Department of Pathology, Medical School, Xi'an Jiaotong University, Xi'an, 710061, China; Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, China.
Department of Pathology, Medical School, Xi'an Jiaotong University, Xi'an, 710061, China; Reproductive Medicine Center, North-West Maternal and Child Hospital, Xi'an, 710003, China.
Eur J Obstet Gynecol Reprod Biol. 2019 Feb;233:84-92. doi: 10.1016/j.ejogrb.2018.11.028. Epub 2018 Dec 14.
The objective is to systematically review and synthesize the literature on the efficacy with two different cryopreservation methods used for human spermatozoa and evaluate whether vitrification protocol and quality of sperm influence effect estimates.
The following electronic databases were searched up to September 2017: Pubmed, Embase and Web of Science. The search strategy used the following the relevant medical subject heading (MeSH) terms, keywords, and word variants for: sperm parameters, conventional freezing, and vitrification. Queries were limited to those involving humans. Randomized controlled trials (RCTs) that published in English languages were considered eligible. Studies and references were included if they reported total motility, progressive motility, morphology, or DNA fragmentation index (DFI) for vitrified or conventional cryopreserved human spermatozoa. Patients recruited in RCTs considering sperm vitrification as one of the experimental arms and conventional freezing (including slow freezing or vapor fast freezing) sperm control as the other. Studies that had high risks of allocation concealment were excluded when performing sensitivity analysis. We specified 2 subgroup variables, including vitrification protocol and quality of spermatozoa cryopreserved, to investigate sources of heterogeneity. A meta-analysis was performed using a random effects (I > 50%) or fixed effects (I < 50%) model to calculate weighted mean differences (MD) and 95% CI.
RESULT(S): The search yielded a total of 2428 articles and 13 RCTs were included for analysis. They involved 486 vitrified and 486 conventional cryopreserved sperm samples. Four sperm parameters were reported as mean differences and based on adjusted estimates in all included studies. Meta-analysis of these studies showed significantly higher total motility [weighted mean differences (WMD) 6.98; 95% confidence interval (CI) 2.94; 11.02; P < 0.0001] and progressive motility [WMD 4.59; 95% CI 0.78; 8.39; P = 0.02] of past-thawed sperm following vitrification compared with conventional freezing methods. However, DNA fragmentation index (DFI) [WMD -1.18; 95% CI -2.81; 0.45; P = 0.16] and morphology [WMD 0.11; 95% CI -0.42; 0.63; P = 0.69] of past-thawed sperm are similar between two freezing groups. Subgroup analysis shown that the vitrification protocol and quality of spermatozoa are potential risk factors for the efficacy of vitrification. Higher past-thawed sperm parameters following the cryoprotectants-free (CPAs-free) vitrification were observed, as well as a lower past-thawed sperm parameters with the cryoprotectants-presence (CPAs-presence) vitrification, which could reflect the CPAs related cytotoxicity. Meanwhile, vitrification had higher ability in preservation of high quality of spermatozoa compared with vitrification of low quality spermatozoa.
CONCLUSION(S): According to the results of present meta-analysis, vitrification is superior to conventional freezing methods in preservation of spermatozoa, regarding total and progressive motility. However, the efficacy of vitrification is influence by using different vitrification protocol and cryopreservation of different quality spermatozoa. It is must emphasized that the results of present meta-analysis is limited by the small number of studies of variable vitrification protocol. Further well conducted studies are required to confirm the efficacy of vitrification in cryopreservation of spermatozoa, in addition, allow the examination of the two cryopreservation methods in terms of pregnancy achievement and determination of the role of clinical variable on efficacy of vitrification.
系统回顾和综合关于两种不同人类精子冷冻保存方法疗效的文献,并评估玻璃化方案和精子质量是否会影响效应估计值。
检索截至2017年9月的以下电子数据库:PubMed、Embase和Web of Science。检索策略使用了以下相关医学主题词(MeSH)术语、关键词和词变体:精子参数、传统冷冻和玻璃化。检索仅限于涉及人类的研究。以英语发表的随机对照试验(RCT)被视为合格。如果研究报告了玻璃化或传统冷冻保存的人类精子的总活力、前向运动力、形态或DNA碎片指数(DFI),则纳入研究和参考文献。在RCT中招募的患者,将精子玻璃化作为实验臂之一,将传统冷冻(包括慢速冷冻或气相快速冷冻)精子作为对照。在进行敏感性分析时,排除分配隐藏风险高的研究。我们指定了2个亚组变量,包括玻璃化方案和冷冻保存的精子质量,以研究异质性来源。使用随机效应(I>50%)或固定效应(I<50%)模型进行荟萃分析,以计算加权平均差(MD)和95%置信区间(CI)。
检索共获得2428篇文章,纳入13项RCT进行分析。它们涉及486个玻璃化精子样本和486个传统冷冻精子样本。在所有纳入研究中,四项精子参数报告为平均差并基于调整后的估计值。这些研究的荟萃分析表明,与传统冷冻方法相比,玻璃化后复苏精子的总活力[加权平均差(WMD)6.98;95%置信区间(CI)2.94;11.02;P<0.0001]和前向运动力[WMD 4.59;95%CI 0.78;8.39;P=0.02]显著更高。然而,两个冷冻组复苏精子的DNA碎片指数(DFI)[WMD -1.18;95%CI -2.81;0.45;P=0.16]和形态[WMD 0.11;95%CI -0.42;0.63;P=0.69]相似。亚组分析表明,玻璃化方案和精子质量是玻璃化疗效的潜在风险因素。观察到无冷冻保护剂(CPAs-free)玻璃化后复苏精子参数较高,而有冷冻保护剂(CPAs-presence)玻璃化后复苏精子参数较低,这可能反映了CPAs相关的细胞毒性。同时,与低质量精子的玻璃化相比,玻璃化在保存高质量精子方面具有更高的能力。
根据目前荟萃分析的结果,在精子总活力和前向运动力方面,玻璃化在精子保存方面优于传统冷冻方法。然而,玻璃化的疗效受不同玻璃化方案和不同质量精子冷冻保存的影响。必须强调的是,目前荟萃分析的结果受到玻璃化方案研究数量较少的限制。需要进一步进行高质量的研究来证实玻璃化在精子冷冻保存中的疗效,此外,还需研究这两种冷冻保存方法在实现妊娠方面的情况,并确定临床变量对玻璃化疗效的作用。